International Isotopes, Inc. engages in the manufacture of nuclear medicine calibration and reference standards cobalt tele therapy sources, as well as radioisotopes and radiochemical for medical research and clinical devices. The company is headquartered in Idaho Falls, Idaho and currently employs 41 full-time employees. The firm's segments include Theranostics Products, Cobalt Products, Nuclear Medicine Standards, Medical Device Products and Fluorine Products. Theranostics Products segment includes production and distribution of its generic sodium iodide I-131 drug product for the treatment of hyperthyroidism and carcinoma of the thyroid. Cobalt Products segment includes the production of bulk cobalt (cobalt-60), fabrication of cobalt capsules for radiation therapy and various industrial applications. Nuclear Medicine Standards segment consists of the manufacture of sources and standards associated with Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) imaging. Fluorine Products segment is involved in the production of small-scale qualification samples of high-purity fluoride gas for various industrial applications. The company is working to launch the RadVent brand of medical devices.
Follow-Up Questions
International Isotopes Inc (INIS) の株価収益率はいくらですか?
International Isotopes Inc の株価収益率は 3641.8848 です。
International Isotopes Inc のCEOは誰ですか?
Mr. Shahe Bagerdjian は International Isotopes Inc の President で、2023 から在籍しています。
INIS の株価パフォーマンスは?
INIS の現在の価格は $0.05 で、最終取引日から 0% decreased 変動しました。
International Isotopes Inc の主な事業テーマや業界は?
International Isotopes Inc は Life Sciences Tools & Services 業界、セクターは Health Care に属しています。